Latest Updates

Alan G. Rosenbloom, President & CEO of Senior Care Pharmacy Coalition, explains how failing to properly define the various long-term care pharmacies under current federal law places seniors' care at risk.

AmerisourceBergen and our global businesses are highly engaged during the ongoing spread of the novel COVID-19 “Coronavirus.”

APhA Senior Lobbyist Alicia Kerry Mica, a key player in the coalition of pharmacy stakeholders working to end abusive PBM practices, sat down with Pharmacy Today to share the good, the bad, and the ugly in the fight to end DIR fees.

With 2020 state legislative sessions in full swing (39 state legislatures in session this week), issues like drug pricing, pharmacy Medicaid reimbursement, pharmacist scope of practice and PBM transparency are being debated in statehouses across the country.

Last week, the National Community Pharmacists Association (NCPA) shared a new study published by XIL Consulting showing how DIR fees charged by PBMs are negatively impacting pharmacies and patients.